James E Flynn Insider Trading $MDCO MEDICINES CO /DE
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
James E Flynn in MEDICINES CO /DE
Trading Symbol: MDCOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,035,472 shares
Current Value: $140,542,354
Latest Transaction: Apr 06 2011
$MDCO Market Capitalization: $3.32B
$MDCO Previous Close: $46.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in MEDICINES CO /DE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.20 | 24,765 | 401,193 | 3,035,472 | 3.1 M to 3 M (-0.81 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.20 | 18,835 | 305,127 | 2,303,811 | 2.3 M to 2.3 M (-0.81 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.35 | 3,409 | 55,737 | 3,060,237 | 3.1 M to 3.1 M (-0.11 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.35 | 2,591 | 42,363 | 2,322,646 | 2.3 M to 2.3 M (-0.11 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 30,887 | 505,620 | 3,063,646 | 3.1 M to 3.1 M (-1.00 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 23,490 | 384,531 | 2,325,237 | 2.3 M to 2.3 M (-1.00 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.39 | 86,166 | 1,412,261 | 3,094,533 | 3.2 M to 3.1 M (-2.71 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.39 | 65,534 | 1,074,102 | 2,348,727 | 2.4 M to 2.3 M (-2.71 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.36 | 17,259 | 282,357 | 3,180,699 | 3.2 M to 3.2 M (-0.54 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.36 | 13,126 | 214,741 | 2,414,261 | 2.4 M to 2.4 M (-0.54 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 14,201 | 231,192 | 3,197,958 | 3.2 M to 3.2 M (-0.44 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 10,799 | 175,808 | 2,427,387 | 2.4 M to 2.4 M (-0.44 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.38 | 39,231 | 642,604 | 3,212,159 | 3.3 M to 3.2 M (-1.21 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.38 | 29,837 | 488,730 | 2,438,186 | 2.5 M to 2.4 M (-1.21 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 5,681 | 92,998 | 3,251,390 | 3.3 M to 3.3 M (-0.17 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 4,319 | 70,702 | 2,468,023 | 2.5 M to 2.5 M (-0.17 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 6,249 | 102,296 | 3,257,071 | 3.3 M to 3.3 M (-0.19 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 4,751 | 77,774 | 2,472,342 | 2.5 M to 2.5 M (-0.19 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 14,622 | 238,631 | 3,263,320 | 3.3 M to 3.3 M (-0.45 %) |
Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 11,120 | 181,478 | 2,477,093 | 2.5 M to 2.5 M (-0.45 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.30 | 10,078 | 164,271 | 3,277,942 | 3.3 M to 3.3 M (-0.31 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.30 | 7,822 | 127,499 | 2,488,213 | 2.5 M to 2.5 M (-0.31 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 4,305 | 70,258 | 3,288,020 | 3.3 M to 3.3 M (-0.13 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 3,341 | 54,525 | 2,496,035 | 2.5 M to 2.5 M (-0.13 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 53,808 | 875,994 | 3,292,325 | 3.3 M to 3.3 M (-1.61 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 41,764 | 679,918 | 2,499,376 | 2.5 M to 2.5 M (-1.64 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 22,701 | 369,572 | 3,346,133 | 3.4 M to 3.3 M (-0.67 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 17,619 | 286,837 | 2,541,140 | 2.6 M to 2.5 M (-0.69 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 10,403 | 169,777 | 3,368,834 | 3.4 M to 3.4 M (-0.31 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 8,074 | 131,768 | 2,588,759 | 2.6 M to 2.6 M (-0.31 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.51 | 55,013 | 908,265 | 3,379,237 | 3.4 M to 3.4 M (-1.60 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.51 | 42,701 | 704,994 | 2,566,833 | 2.6 M to 2.6 M (-1.64 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.48 | 1,288 | 21,226 | 3,434,250 | 3.4 M to 3.4 M (-0.04 %) |
Apr 01 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.48 | 998 | 16,447 | 2,609,534 | 2.6 M to 2.6 M (-0.04 %) |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Option Exercise | X | 12.50 | 1,736 | 21,700 | 0 | |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Option Exercise | X | 12.50 | 1,399 | 17,488 | 0 | |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Option Exercise | X | 11.00 | 1,244 | 13,684 | 0 | |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Option Exercise | X | 11.00 | 942 | 10,362 | 0 | |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | X | 12.50 | 173,600 | 2,170,000 | 3,435,538 | 3.3 M to 3.4 M (+5.32 %) |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | X | 12.50 | 139,900 | 1,748,750 | 2,610,532 | 2.5 M to 2.6 M (+5.66 %) |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | X | 11.00 | 124,400 | 1,368,400 | 3,261,938 | 3.1 M to 3.3 M (+3.96 %) |
Oct 19 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | X | 11.00 | 94,200 | 1,036,200 | 2,470,632 | 2.4 M to 2.5 M (+3.96 %) |
Sep 13 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | P | 13.09 | 50,188 | 656,961 | 3,137,538 | 3.1 M to 3.1 M (+1.63 %) |
Sep 13 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | P | 13.09 | 37,861 | 495,600 | 2,376,432 | 2.3 M to 2.4 M (+1.62 %) |
Aug 09 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 11.97 | 5,762 | 68,971 | 3,087,350 | 3.1 M to 3.1 M (-0.19 %) |
Aug 09 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 11.97 | 4,365 | 52,249 | 2,338,571 | 2.3 M to 2.3 M (-0.19 %) |
Aug 09 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | P | 12.05 | 379,546 | 4,573,529 | 3,093,112 | 2.7 M to 3.1 M (+13.99 %) |
Aug 09 2010 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Buy | P | 12.05 | 287,494 | 3,464,303 | 2,342,936 | 2.1 M to 2.3 M (+13.99 %) |
Page: 1